Skip to main content
DNA Labs India

NPHP1 Gene Joubert syndrome type 4 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

NPHP1 Gene Joubert syndrome type 4 NGS Genetic Test

Short Name: NPHP1 JS Type 4 NGS Test

Also known as: Joubert Syndrome Type 4 Genetic Test, NPHP1 Gene Mutation Analysis, JBTS4 NGS Test, NPHP1 Sequencing Test, Joubert Syndrome NPHP1 Panel

NPHP1 Gene Joubert syndrome type 4 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS), MLPA for copy number variant detection, Sanger confirmation of pathogenic variants on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Results are delivered through the online patient portal, via email, or WhatsApp. Urgent cases may be prioritised upon physician request.. Free home collection in 300+ cities across India.

NGS Genetic TestUnisexAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify pathogenic or likely pathogenic variants in the NPHP1 gene that cause Joubert Syndrome Type 4. Molecular confirmation aids in establishing a definitive diagnosis, differentiating JBTS4 from other genetic causes of cerebellar malformation, estimating recurrence risk for family members, facilitating carrier testing, and enabling informed reproductive decision-making including prenatal or preimplantation genetic diagnosis.

Test Code
1654
CPT Code
81479
ICD Code
Q04.3
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Results are delivered through the online patient portal, via email, or WhatsApp. Urgent cases may be prioritised upon physician request.
Fasting Required
No
Method
Next-Generation Sequencing (NGS), MLPA for copy number variant detection, Sanger confirmation of pathogenic variants
Step 1

Sample Collection

A genetic counselling session is recommended prior to testing to draw a pedigree chart of family members affected with Joubert Syndrome or related ciliopathies. Provide complete clinical history, including neurological and renal findings, family history, and any previous genetic test reports. No fasting is required. Inform the laboratory of any recent blood transfusions.

Method: Venipuncture / Heel prick (infants)

Step 2

Laboratory Analysis

A peripheral venous blood sample (3-5 mL) will be collected in an EDTA (lavender-top) tube. For infants, a heel prick with collection on an FTA card may be performed. The collection procedure typically takes 5-10 minutes and is performed by a trained phlebotomist.

Step 3

Report Delivery

The sample is labelled, stored at ambient room temperature, and transported to the DNA Labs India testing facility under controlled conditions. Avoid exposure to extreme temperatures. Results are typically available within 3-4 weeks and are delivered via the online portal, email, or WhatsApp.

Timeline: Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Results are delivered through the online patient portal, via email, or WhatsApp. Urgent cases may be prioritised upon physician request.

Patient Instructions

1
Before the Test:A genetic counselling session is recommended before testing. Provide detailed clinical history, neuroimaging reports (especially brain MRI showing molar tooth sign if available), renal function test results, and a complete family pedigree. No fasting is required. Inform the lab of any recent blood transfusions or bone marrow transplants.
2
During the Test:A blood sample (3-5 mL in EDTA tube) or blood on FTA card is collected by a trained phlebotomist. The procedure is minimally invasive and takes approximately 5-10 minutes. Free home sample collection is available across India for online bookings.
3
After the Test:Post-test genetic counselling is strongly recommended to interpret the findings, understand recurrence risk, and discuss management options. If pathogenic variants are identified, referral for multidisciplinary evaluation (nephrology, ophthalmology, developmental paediatrics) is advised. Family members may benefit from targeted carrier testing.

About This Test

Who Should Get This Test

The purpose of this test is to identify pathogenic or likely pathogenic variants in the NPHP1 gene that cause Joubert Syndrome Type 4. Molecular confirmation aids in establishing a definitive diagnosis, differentiating JBTS4 from other genetic causes of cerebellar malformation, estimating recurrence risk for family members, facilitating carrier testing, and enabling informed reproductive decision-making including prenatal or preimplantation genetic diagnosis.

How to Prepare

  • Collect 3-5 mL peripheral venous blood in an EDTA (lavender-top) vacutainer tube.
  • Alternatively, one drop of blood on an FTA card is acceptable.
  • Gently invert the tube 8-10 times immediately after collection to prevent clotting.
  • Label the sample clearly with patient name, date of birth, and unique identifier.
  • Store and transport at ambient room temperature (15-30°C). Do not freeze.
  • Do not collect within 4-6 weeks of a blood transfusion.
  • Free home sample collection is available for online bookings across India.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Joubert Syndrome Type 4 is a rare but clinically significant cause of cerebellar hypoplasia and developmental delay in children. Molecular confirmation through NPHP1 gene analysis via NGS is essential for establishing a definitive diagnosis, guiding surveillance for renal and hepatic complications, and enabling informed genetic counselling for affected families. Early identification allows timely multidisciplinary intervention involving neurology, nephrology, and ophthalmology teams."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 mL peripheral venous blood
ContainerEDTA (Lavender Top) tube or FTA Card
Collection MethodVenipuncture / Heel prick (infants)

Sample Stability

Sample Rejection Criteria:
  • Clotted blood sample in EDTA tube
  • Insufficient sample volume
  • Heavily haemolysed or degraded sample
  • Sample collected within 4-6 weeks of blood transfusion
  • Unlabelled or mislabelled samples
  • Sample received without clinical history or test requisition form

Understanding Your Results

The NPHP1 Gene Joubert Syndrome Type 4 NGS Genetic Test report includes a detailed analysis of all detected variants in the NPHP1 gene. Variants are classified according to ACMG/AMP guidelines. A positive result identifying biallelic pathogenic or likely pathogenic variants confirms the molecular diagnosis of Joubert Syndrome Type 4. The presence of only one pathogenic variant suggests carrier status. Negative results do not completely exclude Joubert syndrome, as mutations in other genes can cause similar phenotypes. Genetic counselling is strongly recommended for result interpretation.
📊

Molecular diagnosis of Joubert Syndrome Type 4 confirmed. Autosomal recessive inheritance confirmed. Parents are expected carriers. Genetic counselling recommended for family planning and surveillance.

Diagnostic

📊

Probable diagnosis; further evaluation including segregation analysis in parents and clinical correlation is advised.

Uncertain — Requires follow-up

📊

Carrier status for Joubert Syndrome Type 4. The individual is typically unaffected but carries one mutated copy. Carrier testing for partner recommended if family planning is relevant.

Carrier

📊

Variant of uncertain significance identified. Not sufficient for diagnosis. Clinical correlation and periodic reanalysis recommended as variant databases are updated.

Uncertain

📊

NPHP1 gene mutations not identified. Does not rule out Joubert syndrome caused by other genes. Consider comprehensive Joubert syndrome gene panel or whole exome sequencing.

Negative

⚠️ When to Consult a Doctor:

Consult your neurologist or clinical geneticist if the test identifies any pathogenic or likely pathogenic variant, if a variant of uncertain significance (VUS) is found, or if clinical symptoms persist despite a negative result. Families with a confirmed diagnosis should discuss surveillance for renal, hepatic, and ocular complications with their healthcare team. Genetic counselling is recommended for reproductive planning.

Limitations

  • This test analyses only the NPHP1 gene; other Joubert syndrome-associated genes are not covered.
  • Deep intronic variants, regulatory region variants, and mitochondrial DNA variants may not be detected.
  • The clinical significance of some detected variants may remain uncertain (VUS).
  • This test does not replace clinical evaluation and neuroimaging.
  • Results are most informative when interpreted in conjunction with clinical findings and family history.

Risks & Considerations

  • Minor bruising or discomfort at the venipuncture site
  • Very rare risk of infection at the needle insertion site
  • Potential psychological impact of genetic diagnosis — genetic counselling recommended
  • Identification of variants of uncertain significance may cause anxiety
  • Possible incidental findings unrelated to Joubert syndrome (in comprehensive panels)

Interfering Factors

  • Degraded or insufficient DNA quality from the sample
  • Recent blood transfusion within 4-6 weeks prior to sample collection
  • Contamination during sample collection or transport
  • Haematological malignancies affecting white cell population

Compare With Similar Tests

TestNPHP1 Gene Joubert syndrome type 4 NGS Genetic Test
ComparisonNPHP1 Gene Joubert syndrome type 4 NGS Genetic Test

Frequently Asked Questions

What is Joubert Syndrome Type 4?
Joubert Syndrome Type 4 (JBTS4) is a rare autosomal recessive genetic disorder caused by mutations in the NPHP1 gene on chromosome 2q13. It is part of the Joubert syndrome and related disorders (JSRD) spectrum, characterised by cerebellar vermis hypoplasia, the hallmark 'molar tooth sign' on brain MRI, hypotonia, ataxia, abnormal breathing patterns, abnormal eye movements, intellectual disability, and potential renal (nephronophthisis) and ocular (retinal dystrophy) involvement.
What gene is analysed in this test?
This test specifically analyses the NPHP1 gene (Nephrocystin-1 gene), located on chromosome 2q13. The NPHP1 gene encodes nephrocystin-1, a protein essential for normal primary cilium function in the kidney, brain, and retina. Mutations in this gene cause both Joubert Syndrome Type 4 and nephronophthisis type 1.
What is NGS technology and why is it used for this test?
Next-Generation Sequencing (NGS) is an advanced molecular technique that enables high-throughput, parallel sequencing of DNA. For the NPHP1 Gene Joubert Syndrome Type 4 test, NGS allows comprehensive analysis of the entire gene, including detection of single nucleotide variants (SNVs), small insertions and deletions (InDels), and copy number variations (CNVs). This provides significantly higher sensitivity and specificity compared to traditional Sanger sequencing.
What sample types are accepted for this test?
The test accepts three sample types: (1) Peripheral venous blood (3-5 mL) collected in an EDTA lavender-top vacutainer tube, (2) Pre-extracted DNA, or (3) One drop of blood collected on an FTA card. Free home sample collection is available across India for blood samples.
How long does it take to receive the test results?
Results are typically available within 3 to 4 weeks from the date the sample is received at the DNA Labs India laboratory. Reports are delivered through the online patient portal, via email, or WhatsApp. In urgent clinical situations, please discuss expedited processing options with our team.
What is the cost of the NPHP1 Gene Joubert Syndrome Type 4 NGS Genetic Test?
The cost of the NPHP1 Gene Joubert Syndrome Type 4 NGS Genetic Test at DNA Labs India is Rs 20000. This price includes NGS sequencing, variant analysis and interpretation, a clinical test report, raw data files (FASTQ and VCF), and free home sample collection across India.
Is this test available across India?
Yes. DNA Labs India offers free home sample collection for the NPHP1 Gene Joubert Syndrome Type 4 NGS Genetic Test across India, including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Pune, Ahmedabad, Jaipur, Lucknow, and hundreds of other cities and towns. You can book online for convenient home collection.
Is genetic counselling required before taking this test?
While not mandatory, genetic counselling before and after testing is strongly recommended. A pre-test counselling session helps in understanding the implications of the test, drawing a family pedigree, and preparing the patient and family for possible outcomes. Post-test counselling is essential for interpreting the results and discussing recurrence risk, management options, and family planning.
Can this test be used for prenatal diagnosis?
Yes. If both parents have been identified as carriers of NPHP1 mutations, prenatal genetic diagnosis can be performed on chorionic villus sampling (CVS) or amniocentesis samples. Preimplantation genetic testing (PGT) during IVF is also an option. Discuss these options with your clinical geneticist.
What does a negative test result mean?
A negative result means no pathogenic or likely pathogenic variants were identified in the NPHP1 gene. However, this does not completely rule out Joubert syndrome, as mutations in over 35 other genes can cause similar clinical features. Your physician may recommend a comprehensive Joubert syndrome gene panel or whole exome sequencing (WES) if clinical suspicion remains high.
Does DNA Labs India provide raw data files with the test report?
Yes. DNA Labs India is committed to transparency and provides raw data files including FASTQ files (raw sequencing reads) and VCF files (variant call format) along with the conclusive clinical test report. This allows patients and their healthcare providers to seek second opinions or perform additional analyses as needed.
What is the molar tooth sign and how is it related to this test?
The molar tooth sign (MTS) is a characteristic finding on brain MRI in individuals with Joubert syndrome. It appears as a deepened interpeduncular fossa, thickened and elongated superior cerebellar peduncles, and vermian hypoplasia — resembling a molar tooth in axial view. While the MTS is a strong clinical indicator, molecular confirmation through NPHP1 gene testing (or a broader gene panel) is required to establish the specific genetic subtype and enable targeted genetic counselling.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.